Markets
Longevity startup Biopeak has secured US$2.7m in a follow-on round led by NKSquared, the investment vehicle of Zerodha co-founder Nikhil Kamath. This is Kamath's second investment in the company after he put US$1.43m into the health optimisation startup in August 2024. Founded in 2025 by Rishi Pardal and Shiva Subramanian, Biopeak operates India’s first specialised [...]
Boots will run an obesity drug trial for a new type 2 diabetes medicine at selected stores in England, the chain has revealed. Boots has partnered with Civia Health to set up clinical research sites at four stores in Nottingham, Brighton, Peterborough and Birmingham, connecting communities to local research opportunities for obesity, diabetes and cardiovascular [...]
L-Nutra will establish an Abu Dhabi centre to produce medical and longevity nutrition for the Middle East and North Africa. The company has added US$36.5m to its Series D, taking the round to US$83.5m and supporting plans for a joint venture to make medical and longevity nutrition for the region. Founded in 2009 by longevity [...]
Insilico Medicine has agreed a US$66m deal with a Chinese biotech for half of the rights to a brain-penetrant Parkinson's drug. Under the agreement, the artificial intelligence-powered drug developer will take the lead on bringing the preclinical asset, dubbed ISM8969, into a phase 1 trial. Hygtia Therapeutics will then take over for further studies and [...]
Exciva has raised US$59.4m in series B funding to support a phase 2 trial of its Alzheimer's therapy. The clinical-stage biopharmaceutical company is developing treatments for behavioural symptoms associated with the condition. Neuropsychiatric symptoms such as agitation and other behavioural symptoms affect up to 90 per cent of patients with severe Alzheimer's disease, driving caregiver [...]
SciNeuro Pharmaceuticals has entered a worldwide licensing and collaboration agreement with Novartis to advance its amyloid beta-targeted antibody programme for Alzheimer's disease. The programme has identified de novo antibody candidates that incorporate what SciNeuro describes as its proprietary blood-brain barrier shuttle technology, designed to help drugs cross the protective barrier around the brain, and which [...]
L-Nutra has raised US$36.5m in series D funding for what it describes as science-driven nutrition for longevity and nutrition as medicine. The round brings its series D total to US$83.5m, the company said. As part of the investment, Mubadala and L-Nutra will establish a local joint venture in Abu Dhabi to produce scientific medical nutrition [...]
London-based biotech Engitix has raised US$25m in a Series A extension, with billionaire hedge fund founder Mike Platt backing the company for the second time. The preclinical company is developing therapies that target the extracellular matrix (ECM), the structural material surrounding cells in tissues, in solid tumours and fibrosis. Founder Giuseppe Mazza said the company [...]
TECregen has raised CHF 10m [£9,300,000] in seed financing to develop therapies aimed at rejuvenating the thymus, a gland that produces immune cells. The Basel-based biotechnology company is developing biologics designed to revitalise thymic epithelial cells, which support T-cell production. T-cells are a type of white blood cell crucial for immune function. The thymus shrinks [...]
Corsera Health has raised US$80m in Series A funding to develop preventive RNAi medicines and AI tools to predict and prevent cardiovascular disease. The Boston-based company has begun dosing patients in a Phase 1 clinical trial of COR-1004, a drug designed to lower cholesterol by silencing PCSK9, a gene that regulates LDL cholesterol in the [...]
